OR WAIT null SECS
Growth and Advancements in Fill/Finish
Employing novel technologies and more patient-centric approaches
Delving into Biopharmaceutical Development and Manufacturing
Quality Considerations in Changing Excipient Providers
August 03, 2022
Industry is adapting to the increasing complexity and poor solubility and bioavailability of molecules in the pipeline.
The purpose of this article was to demonstrate the application of a new thermogelling matrix in the healing of wounds.
Further advances in construct design and manufacturing scalability are still needed.
This article provides an overview of solutions to address key challenges facing vaccine developers or CDMOs wishing to build their own commercial-scale mRNA production facilities.
The option of using prefilled syringes for vaccinations is not (yet) available for all types of vaccines. Stakeholders are working to expand that option while also pursuing other non-traditional routes of administration.
August 02, 2022
Automated finished product inspection has been widely adopted in the bio/pharmaceutical industry.
Successful digital transformation in biopharma requires an integrated approach to the data lifecycle.
Screening for apparent total nitrosamine content with a thermal energy analyzer offers a rapid way of identifying contaminated drug products.
Automation of pharmaceutical packaging saves costs and time, say contract packagers.
Pharmaceutical Technology Europe spoke with representatives from the European Directorate for the Quality of Medicines & Healthcare (EDQM) about API quality from their perspective.